Ledger.Open graph →
SEC Form D · filed November 12, 2020

Prometheus Biosciences, Inc

Offering
$130.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

James D. Laur · San Diego, CADirectorJoseph C. Papa · San Diego, CADirectorWilliam C. Sandborn, M.D · San Diego, CADirectorShierley C. Widjaja · San Diego, CADirectorTadataka T. Yamada, M.D · San Diego, CADirectorMark T. Mckenna · San Diego, CAExec · DirectorLauren G. Otsuki · Del Mar, CAExecJoy Ghosh, Ph.D · San Diego, CADirectorMartin Hendrix, Ph.D · San Diego, CADirectorAdam C. Stone · San Diego, CADirectorKeith W. Marshall, Ph.D · San Diego, CAExecLaurens W. Kruidenier, Ph.D · San Diego, CAExecAllison W. Luo, M.D · San Diego, CAExecJoy Ghosh, Ph.D · San Diego, CADirectorMartin Hendrix, Ph.D · San Diego, CADirectorJames D. Laur · San Diego, CADirectorJoseph C. Papa · San Diego, CADirectorWilliam C. Sandborn, M.D · San Diego, CADirectorAdam C. Stone · San Diego, CADirectorShierley C. Widjaja · San Diego, CADirectorTadataka T. Yamada, M.D · San Diego, CADirectorMark T. Mckenna · San Diego, CAExec · DirectorKeith W. Marshall, Ph.D · San Diego, CAExecLaurens W. Kruidenier, Ph.D · San Diego, CAExecAllison W. Luo, M.D · San Diego, CAExecLauren G. Otsuki · Del Mar, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗